Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Immunome, Inc. reported a quarterly loss of $0.34 per share, beating estimates by 57.50%. - The company posted revenues of $1.03 million, missing estimates by 74.28%. - Immunome shares have gained 45.9% YTD, outperforming the S&P 500. - Earnings outlook for Immunome is mixed, with a Zacks Rank #3 (Hold). - Industry outlook could impact stock performance, with Medical - Biomedical and Genetics ranking in the top 37%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Immunome, Inc. reported a quarterly loss of $0.34 per share, beating estimates by 57.50%.
- The company posted revenues of $1.03 million, missing estimates by 74.28%.
- Immunome shares have gained 45.9% YTD, outperforming the S&P 500.
- Earnings outlook for Immunome is mixed, with a Zacks Rank #3 (Hold).
- Industry outlook could impact stock performance, with Medical - Biomedical and Genetics ranking in the top 37%.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.